Share the Easter spirit, not the virus!

Published in Society
Saturday, 18 April 2020 16:24

Easter is a very special occasion for Georgia, when many families come together and share a heartwarming celebration. The community spirit at the heart of Easter includes a sense of responsibility to protect ourselves and others from COVID-19. 

The UN in Georgia commends the people of Georgia for the responsible way they are complying with the protective measures recommended by the Government, guided by the advice of the World Health Organization (WHO). This approach has already reduced the number of cases of infection and saved lives.  We need to continue this trend.

This year we call on every family in Georgia to share the spirit of the celebration, but put the health and the wellbeing of the community first. Please, stay home and avoid gatherings to ensure that you and your loved ones remain healthy in these unheard-of circumstances. 

More than ever, we should make use of modern technology to reconnect with relatives and friends living far and close: physical distancing is not social isolation. Let’s maintain our connections by conducting faith activities in alternative ways.

Adhering to physical distancing rules protect ourselves, our beloved ones and the entire community. It protects in particular the most vulnerable: older people, people living with chronic health conditions and immune suppression.  

Following the Government's recommendations will also protect healthcare workers and public health professionals who have been bravely and tirelessly, day and night, fighting the pandemic since the very first case. We need to stay home to let them stay at work healthy and caring for the sick ones.

The UN in Georgia calls on all living in Georgia to continue play your essential role in fighting COVID-19 thus contributing to the national response by staying at home!

The UN wishes all those in Georgia who celebrate a Happy Easter!

Related information: “Practical considerations and recommendations for religious leaders and faith-based communities in the context of COVID-19,” was published by the World Health Organization to guide religious leaders, faith-based organizations, and faith communities during COVID-19.Link

Read 240 times

Related items

  • UNICEF with the support from USAID/Georgia is organizing the information sessions in Samtskhe-Javakheti region about COVID-19 vaccination
    UNICEF with the support from USAID/Georgia is organizing the information sessions in Samtskhe-Javakheti region about COVID-19 vaccination. UNICEF Representative in Georgia, Ghassan Khalil together with the representatives from National Center for Disease Control and Public Health, and health experts visited Akhalkalaki and Akhaltsikhe.
    The first meeting is happening now with the Orthodox Religious Leaders, to discuss topics such are COVID-19 vaccination, immunization programmes in Georgia and etc. The meeting will end with a discussion.
    Vaccines save millions of lives each year. The development of safe and effective COVID-19 vaccines is a huge step forward in our global effort to end the pandemic and to get back to doing more of the things we enjoy with the people we love.
    UNICEF’s work is grounded on empirical data, independent evaluation, rigorous research and thoughtful analysis.
    UNICEF supports and uses research, evaluations and data to determine what works best for children. We draw on sound evidence to create programmes, campaigns and initiatives where they are most needed. Explore our reports, data and research.

     Press Service of the UNICEF Georgia

  • All you need to know about vaccination in the time of COVID-19

    Produced in cooperation with WHO and EUvsDisinfo

    1. 1.       What are the benefits of being vaccinated?

    Today, there are vaccines to protect against at least 20 diseases, such as diphtheria, tetanus, influenza and measles. Together, these vaccines save the lives of up to 3 million people every year – that’s more than five lives every minute, helping people to grow up and grow old in good health.

    Vaccinations are an integral part of the panoply of healthcare that has vastly extended the length and quality of our lives in the past hundred years. Most of us received several vaccines as children, protecting us against diseases that just a few generations ago killed and crippled thousands. And our elderly and vulnerable populations are vaccinated every year to protect them against annual strains of influenza. We know that vaccinated children do better at school, and their communities benefit economically. Vaccines advance global welfare and are among the most cost-effective means of doing so.

    There are now several vaccines that are in use against COVID-19, and several hundred million vaccine doses have already been administered. These vaccines protect against the disease and its consequences by developing an immune response to the virus. 

    Getting vaccinated will also help protect people around you, because if you are protected from developing severe COVID-19 disease through vaccination, you are less likely to infect someone else – someone like your elderly parents or grandparents, who are at increased risk for severe illness from COVID-19, or the doctors and nurses on whom we all depend. Exactly how well vaccination will prevent onward transmission is not yet known, however, so it is important to also continue with other prevention measures, like wearing a mask, until everyone around you is also vaccinated.


    1. 2.       Are all COVID-19 vaccines safe?

    All vaccines authorised in the EU to prevent COVID-19 undergo a scientific evaluation by the European Medicines Agency (EMA) and are rigorously monitored to ensure safety. The WHO is working together with the EU and around the world to ensure that the highest safety standards are met for authorised vaccines.

    The EMA has so far approved four vaccines for use in the European Union – those produced by Pfizer-BioNTech, AstraZeneca, Moderna, and Johnson & Johnson. Three others are currently under review, including the Russian Sputnik vaccine.

    Like all vaccines, COVID-19 vaccines have gone through a rigorous, multi-stage testing process, including large trials that involve tens of thousands of people. These trials are specifically designed to identify any common side effects or other safety concerns.

    It’s true that COVID-19 vaccines have been developed and approved at record speeds, but there has been no compromise on safety – on the contrary, the unprecedented international cooperation and vast amounts of funding have enabled huge clinical trials in real life conditions that usually take much longer to achieve, if feasible at all.

    Once a COVID-19 vaccine is introduced, WHO supports work with vaccine manufacturers, health officials in each country, and other partners, to monitor any safety concerns on an ongoing basis.

    As with all medicines, side effects can occur after getting a COVID-19 vaccine, and are usually a sign that the vaccine is working by stimulating the immune system to prepare the body to fight the disease. However, these side effects are transient (24-48 hours), and serious side effects (such as an allergic reaction) are exceedingly rare. The fact is: the risk of the disease by far outweighs the risks of the COVID-19 vaccines.

    You can review COVID-19 vaccines under investigation, evaluation and authorised for use in the EU on the EMA website or find out the latest on the safety of COVID-19 vaccines from the WHO.


    1. 3.       How are the EU and WHO helping with vaccination?

    The European Union last year spent more than €1 billionto support the research and development of vaccines and new therapies to cure COVID-19. The new mRNA technology, which has been vital for the rapid development of several vaccines, has been developed in Europe. The Pfizer-BioNTech vaccine in particular has had strong financial support from the EU (BioNTech has received more than €9 million of EU research funding over the past decade, as well as a €100 million loan from the European Investment Bank in 2020).

    Through its advance purchase agreements, the EU has ordered 1.3 billion vaccine doses from BioNTech/Pfizer, Moderna, AstraZeneca and Johnson & Johnson – significantly more than what it needs to vaccinate its population of 447 million people. The EU intends to share part of these vaccines with its partner countries in parallel to accelerating the EU’s own vaccination plans.

    At the same time, the European Union is one of the biggest supporters of COVAX, a ground-breaking global collaboration to accelerate the development, production, and equitable access to COVID-19 vaccines. The EU’s Team Europe (which combines resources from the EU, its Member States and European financial institutions) supports COVAX with more than €2.2 billion, including €1 billion from the EU budget. This is a key contribution that is helping COVAX to secure 1.3 billion doses of vaccines for 92 low and middle-income countries, including its Eastern Partners, by the end of 2021.

    COVAX has so far published the following allocations of vaccines for the Eastern Partner countries for the period February to May 2021:

    • Armenia: 124,800 doses of AstraZeneca
    • Azerbaijan: 432,000 doses of AstraZeneca
    • Georgia: 129,600 doses of AstraZeneca and 29,250 doses of Pfizer-BioNTech
    • Moldova: 108,000 doses of AstraZeneca and 24,570 doses of Pfizer-BioNTech
    • Ukraine: 1,776,000 doses of AstraZeneca and 117,000 doses of Pfizer-BioNTech

    The first COVID-19 vaccines under the COVAX facility have already arrived in Armenia, Georgia, Azerbaijan, Ukraine and Moldova. Romania has also shipped vaccines to Moldova through the EU Civil Protection Mechanism.

    But the vaccines themselves are only half the story. Equally important is the vaccine infrastructure. Since February 2021, the EU and the WHO have been working together in a major effort to support the deployment of COVID-19 vaccines and vaccination in the six Eastern partner countries. With a total budget of €40 million over three years, this is the largest EU and WHO joint action ever implemented in the European Region.

    Through this programme, the EU and WHO are helping to prepare national infrastructures for the effective receipt and deployment of vaccines. The joint effort includes risk communication and community engagement, support to vaccine supply chain management, vaccination data and safety monitoring, training of health managers and medical staff involved in the vaccination campaign, scheduling of the vaccinations, as well as key logistical support for the delivery and handling of the vaccines and supplies.


    1. 4.       Will the COVID-19 vaccine provide long-term protection? When will this all be over?

    Because COVID-19 vaccines have only been developed and deployed over just the past year,  it’s too early to know exactly how long their protection will last. Data from early studies show that immunity persists for several months but the full duration is not yet known, so continued monitoring will be needed.

    If immunity against coronavirus does not last, then it may be necessary to have a vaccine every year, just as we do with the flu vaccine. 

    As for the impact of COVID-19 vaccines on the pandemic, this will depend on several factors, such as how quickly they are delivered, how many people get vaccinated, and the possible development of new variants of the disease.

    To safely achieve herd immunity against COVID-19, a substantial proportion of a population will need to be vaccinated, lowering the overall opportunities for the virus able to spread in the whole population. The percentage of people who need to be immune, either through prior infection or vaccination, in order to achieve herd immunity varies with each disease (e.g. 95% for measles and around 80% for polio). The proportion of the population that must be vaccinated against COVID-19 to begin inducing herd immunity is not known. 

    It is also not yet known how well vaccination will prevent transmission of the virus to others who may not be protected.

    Therefore, until vaccination is widely available, we have to continue following public health measures – social distancing, wearing masks in public and good hand-washing hygiene – as these play an important role in breaking the virus transmission chain.


    1. 5.       Many of my friends and relatives think it’s all a conspiracy and are suspicious of the vaccine: how can I change their minds?

    It could be a a friend, a loved-one, a colleague or a neighbour. We all know someone who is strongly opposed to vaccination. Often, this fear is driven by belief in anti-vaccine conspiracies, like the untrue but persistent myths that Microsoft is using vaccines to microchip humanity or that vaccines can modify our DNA.

    Unfortunately, the COVID-19 health crisis has provided ample opportunities for the spread of mis- and disinformation, not just in the Eastern partner countries, but all over the world, including in the European Union and the United States.

    Whether deliberately spread to divide people, or driven by genuine concern, false information and conspiracy theories exploit our fears and contribute to existing vaccine hesitancy.

    People may be exposed to misinformation through the media or opinions and rumours spread in person. But increasingly, it is online social networks which fuel the infodemic. By amplifying attention-grabbing posts, social media algorithms actually incentivise the circulation of misinformation and disinformation, allowing false information to spread faster and further than true information.

    In the Eastern Partnership region, one of the key disinformation narratives revolves around the claim that vaccines developed in the West are dangerous. The EUvsDisinfo campaign, the EU’s leading initiative to counter disinformation, is continuously monitoring and analysing the spread and impact of vaccine disinformation in the EaP countries, debunking myths around the narrative that feeds the vaccine war between Russia and the West.

    The EUvsDisinfo initiative has compiled a six-point guide for conversations with vaccine-sceptics to help you along the way with that friend or relative who is distrustful of vaccination. The guide urges you to stay calm, understand, relate, connect with reliable sources, encourage critical thinking, and… know when to stop.


    1. 6.       There’s still a way to go on vaccination, so what other support is available in times of COVID-19?

    The European Union has been in the frontline of COVID-19 support from the moment the pandemic struck. To date, more than €1 billion worth of support has been allocated in emergency relief to cover immediate needs, or for assisting national health systems and the social and economic recovery of the region. 

    The EU and the World Health Organization are working together, not only on vaccine supply, but to support the health sector across the six Eastern partner countries through the Solidarity for Health Initiative, supplying medical devices and personal equipment. Over 11 million items of personal protective equipment, 12,000 lab kits, over 1,500 ventilators, oxygen concentrators and pulse oximeters, and over 20,000 PCR testing kits have been provided as part of this project.

    The EU is also supporting the most vulnerable groups in society, with investments of more than €11 million. Grants of up to €60,000 are given to civil society organisations through the Eastern Partnership Solidarity Programme for projects such as supporting local schools with distance learning, helping women who have lost their jobs, or providing food supplies to the elderly and the disabled. A second programme, COVID-19: Civil Society Resilience and Sustainability, also works with civil society and independent media, helping them to continue providing access to protection and assistance, especially to the most vulnerable groups, as well as accurate information about the pandemic.

    The EU is also helping business to survive this exceptionally difficult time, working closely with financing institutions in the EU Member States and globally to support small business, the self-employed and others across the region to easily access local currency loans and apply for grants to boost their businesses during and after the crisis, channelling support through the EU4Business initiative. You can visit the dedicated COVID-19 support pages on the EU4Business website to find out about support measures for businesses in Armenia, Azerbaijan, Belarus, Georgia, Moldova and Ukraine.

    European financial institutions, such as the European Investment Bank and the European Bank for Reconstruction and Development, have been key players in supporting business credit, but they have also invested billions in supporting public health systems, building economic resilience, digitalisation, renewable energies and green investments, providing both emergency support and longer-term investment to help build a sustainable recovery.

  • United Nations Country Team presents annual progress report for Georgia

    The United Nations Country Team in Georgia today organized a presentation of its achievements in 2020 to report progress in pursuing the joint UN-Georgia strategy “Partnership for Sustainable Development” agreed with the Government for 2016-2020. The event was designed to underscore the commitment by the UN agencies to “Deliver as One” in alignment with national priorities and the Sustainable Development Goals.

    Ilia Darchiashvili, Head of the Administration of the Government of Georgia, in his speech at the virtual presentation stressed the effective and efficient cooperation with the UN.

    “Next year marks the 30th anniversary of Georgia’s membership in the UN. Over these decades, UN support and engagement have been instrumental to the success of our country and today I would like to, once again, thank the UN on behalf of our government. It has been a long journey with growing cooperation to achieve a world where no one is left behind. Throughout this time Georgia has become more actively engaged within the important ongoing processes at the UN, often playing a leading role in different intergovernmental negotiations and consultations across all three pillars of the UN,” said Ilia Darchiashvili. “We look forward to continuing our partnership and remain open and ready for further active cooperation with the UN Country Team. We believe that with joint efforts in the implementation of the 2030 Agenda for Sustainable Development, we can make the world a better place for everyone.”

    Mr. Darchiashvili outlined some areas of fruitful UN-Georgia cooperation: advancement of the sustainable development agenda, strengthening human rights and improvement of socio-economic conditions in Georgia, including the improved resilience of conflict-affected communities. He expressed particular appreciation to the UN Country Team for the dedicated efforts and continued support rendered to Georgia’s response to the COVID-19 pandemic.

    UN Resident Coordinator Sabine Machl underlined the shared commitment to leave no one behind, the overarching motto of the Sustainable Development Goals. She noted that, at USD 57.5 million for 2020, the UN contribution to development efforts in Georgia represented a significant financial mobilization.

    “In 2020, the UN Country Team in Georgia continued to closely work with the Government, Parliament, civil society as well as many other partners to provide assistance in the areas of socio-economic development, protection of the environment, strengthening the rule of law, human rights, gender equality and democratic values, reinforcing social justice, making quality education and healthcare available to all," said Sabine Machl.

    She noted that because of the COVID-19 pandemic the UN Country Team has repurposed over USD 20 million to strengthen institutions at the national and local level to prevent and address the socio-economic impact of the COVID-19 pandemic and to mitigate the impact of the coronavirus outbreak on human lives and livelihoods, with the main focus on the most vulnerable.

    Both, Mr. Darchiashvili and Ms. Machl highlighted their expectation that the new UN Sustainable Development Cooperation Framework – which was signed after intensive consultations throughout last year – will yet give new impetus to the Georgia-UN cooperation for the coming five years.

    Marine Chitashvili, Team Leader of the UN Resident Coordinator’s Office, presented the UN’s achievements in five main areas: 1) Democratic governance; 2) Jobs, livelihoods and social protection; 3) Education; 4) Health; and 5) Human security and community resilience. Among the main achievements in 2020, she outlined: support to the elaboration and adoption of the Code on the Rights of the Child, the 2021-2030 Migration Strategy and the National Youth Policy for 2020-2030; supporting improvements in preschool and primary teaching; support to the government’s implementation of the Decentralization Strategy for 2020-2025; developing the system for vocational education and training to diversify rural occupations and help professionalize farming; assistance to vulnerable groups in conflict-affected communities, and formulating climate change policies and supporting the reduction of the risk of floods and other climate-driven disasters benefitting up to 1.7 million people (40% of population).

    Organised by the United Nations Country Team in Georgia, the event brought together representatives of the Georgian parliament and government ministries.

    Press Release

  • To help Georgia fight the COVID-19 pandemic, the U.S. Government donated three ultra-low temperature freezers to NCDC

    To help Georgia fight the COVID-19 pandemic, the U.S. Government donated three ultra-low temperature freezers to NCDC to support Georgia’s readiness and administration efforts.

    This donation is part of more than $1,000,000 in funding from U.S. EUCOM, provided to Georgia through the Humanitarian Assistance Program.

  • Prime Minister of Georgia and WHO Director-General Spoke about the Importance of WHO Support in Efficient Delivery of Additional Doses of COVID Vaccine to Georgia

    Irakli Garibashvili, Prime Minister of Georgia and Tedros Adhanom Ghebreyesus, Director-General of the World Health Organization (WHO) held a telephone conversation today.

    According to the Head of Government of Georgia, active negotiations are progressing with international partners and pharmaceutical companies on the delivery of additional doses of COVID vaccines to the country in the shortest period of time. During the phone conversation, the Prime Minister of Georgia underlined the profound importance of WHO support in the process.

    Dignitaries reviewed the situation witnessed globally and in Georgia during the pandemic caused by COVID-19 and assessed the performance of vaccination in the country.

    Irakli Garibashvili underlined the profound importance of WHO support in the fight against COVID-19 and expressed his sincere gratitude to Tedros Adhanom Ghebreyesus for the support demonstrated to the country.

    Press Service of the Government Administration

Business News

Georgian Lari Drops in Value against US Dollar

Georgian Lari Drops in Value against US Dollar

Georgian National Currency decreased by 0.0011 GELs against US Dollar. The official exchange rate to...

ENPARD: Czech farmers shares experience with Georgian colleagues

ENPARD: Czech farmers shares experience with Georgian colleagues

Members of eight Georgian cooperatives who have received ENPARD grants have visited the Czech Republ...

Georgian Lari drops in Value against USD

Georgian Lari drops in Value against USD

According to official exchange rate, Geogrian National Currency slightly depreciated against dollar,...

Official exchange Rate of 1 USD equals 2.2459 GEL

Official exchange Rate of 1 USD equals 2.2459 GEL

Georgian National Bank set an official exchange rate, according which 1 US Dollar equals 2.2459 GEL....


« May 2021 »
Mon Tue Wed Thu Fri Sat Sun
          1 2
3 4 5 6 7 8 9
10 11 12 13 14 15 16
17 18 19 20 21 22 23
24 25 26 27 28 29 30


The News Agency,
a part of STARVISION
Media Group.
It made its first
appearance on the Internet..More



Lechkhumi street.43


Phone: (+995 32) 257 91 11




Social Media